Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆Y. Di Filippo, Henri Montaudié, Julie De Quatrebarbes et al.|Annals of Oncology|2020Cited by 30
Does body mass index really predict the response to systemic therapies in metastatic melanoma: A multicenter study from the MelBase French National Cohort?Y. Di Filippo, Wendy Lefevre, Célèste Lebbé et al.|Journal of Clinical Oncology|2020Cited by 1